PROSPECTIVE, MULTICENTER RANDOMIZED GITMO/IIL TRIAL COMPARING INTENSIVE (R-HDS) VERSUS CONVENTIONAL CHEMOIMMUNOTHERAPY (CHOP-R) IN HIGH-RISK FOLLICULAR LYMPHOMA AT DIAGNOSIS: THE HIGHER MOLECULAR REMISSION RATE OF R-HDS ACCOUNTS FOR ITS SUPERIOR CLINICAL PERFORMANCE / LADETTO, M; DE MARCO, F; BENEDETTI, F; VITOLO, U; PATTI, C; RAMBALDI, A; PULSONI, A; MUSSO, M; LIBERATI, AM; OLIVIERI, A; GALLAMINI, A; POGLIANI, E; ROTA SCALABRINI, D; CALLEA, V; DI RAIMONDO, FRANCESCO; PAVONE, V; TUCCI, A; CORTELAZZO, S; LEVIS, A; BOCCADORO, M; MAJOLINO, I; PILERI, A; GIANNI, AM; PASSERA, R; CORRADINI, P; TARELLA,. - 92(2007), pp. 11-11.
Titolo: | PROSPECTIVE, MULTICENTER RANDOMIZED GITMO/IIL TRIAL COMPARING INTENSIVE (R-HDS) VERSUS CONVENTIONAL CHEMOIMMUNOTHERAPY (CHOP-R) IN HIGH-RISK FOLLICULAR LYMPHOMA AT DIAGNOSIS: THE HIGHER MOLECULAR REMISSION RATE OF R-HDS ACCOUNTS FOR ITS SUPERIOR CLINICAL PERFORMANCE |
Autori interni: | |
Data di pubblicazione: | 2007 |
Handle: | http://hdl.handle.net/20.500.11769/84019 |
Appare nelle tipologie: | 4.1 Contributo in Atti di convegno |